CoChat

The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types

Open access
Daniloski, Zharko, Jordan, Tristan X., Ilmain, Juliana K., Guo, Xinyi, Bhabha, Gira, tenOever, Benjamin R., Sanjana, Neville E. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)

Preprint — published as 10.7554/elife.65365 · Paper page

PreprintCited by 108

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

A novel isolate of the SARS-CoV-2 virus carrying a point mutation in the Spike protein (D614G) has recently emerged and rapidly surpassed others in prevalence. This mutation is in linkage disequilibrium with an ORF1b protein variant (P314L), making it difficult to discern the functional significance of the Spike D614G mutation from population genetics alone. Here, we perform site-directed mutagenesis to introduce the D614G variant and show that in multiple cell lines, including human lung epithelial cells, that the D614G mutation is up to 8-fold more effective at transducing cells than wild-type. We demonstrate increased infection using both Spike-pseudotyped lentivirus and intact SARS-CoV-2 virus. Although there is minimal difference in ACE2 receptor binding between the Spike variants, we show that the G614 variant is more resistant to proteolytic cleavage in vitro and in human cells, suggesting a possible mechanism for the increased transduction. This result has important implications for the efficacy of Spike-based vaccines currently under development in protecting against this recent and highly-prevalent SARS-CoV-2 isolate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.06.14.151357

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. 2016, Gapped sequence alignment using artificial neural networks: application to the MHC class I system, Bioinforma. Oxf. Engl, 32, 511, 10.1093/bioinformatics/btv639 · DOI · Paper page
  2. Becerra-Flores, M. , and Cardozo, T. (2020). SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int. J. Clin. Pract. e13525. · DOI · Paper page
  3. Bestle, D. , Heindl, M.R. , Limburg, H. , Van, T.V.L. , Pilgram, O. , Moulton, H. , Stein, D.A. , Hardes, K. , Eickmann, M. , Dolnik, O. , et al. (2020). TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS- CoV-2 in human airway epithelial cells and provide promising drug targets. BioRxiv 2020.04.15.042085. · DOI · Paper page
  4. Bhattacharyya, C. , Das, C. , Ghosh, A. , Singh, A.K. , Mukherjee, S. , Majumder, P.P. , Basu, A. , and Biswas, N.K. (2020). Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes. BioRxiv 2020.05.04.075911. · DOI
  5. Dorp, L. van , Richard, D. , Tan, C.C. , Shaw, L.P. , Acman, M. , and Balloux, F. (2020). No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. BioRxiv 2020.05.21.108506.
  6. 10.3390/v4040557 · DOI · Paper page
  7. Hu, J. , He, C.-L. , Gao, Q.-Z. , Zhang, G.-J. , Cao, X.-X. , Long, Q.-X. , Deng, H.-J. , Huang, L.-Y. , Chen, J. , Wang, K. , et al. (2020). The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera. BioRxiv 2020.06.20.161323.
  8. Korber, B. , Fischer, W.M. , Gnanakaran, S. , Yoon, H. , Theiler, J. , Abfalterer, W. , Foley, B. , Giorgi, E.E. , Bhattacharya, T. , Parker, M.D. , et al. (2020). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. BioRxiv 2020.04.29.069054. · DOI
  9. 10.1128/JVI.78.19.10628-10635.2004 · DOI · Paper page
  10. Ozono, S. , Zhang, Y. , Ode, H. , Tan, T.S. , Imai, K. , Miyoshi, K. , Kishigami, S. , Ueno, T. , Iwatani, Y. , Suzuki, T. , et al. (2020). Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry. BioRxiv 2020.06.15.151779. · DOI
  11. 2020, A large peptidome dataset improves HLA class I epitope prediction across most of the human population, Nat. Biotechnol, 38, 199, 10.1038/s41587-019-0322-9 · DOI · Paper page
  12. 2020, Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies, Cell. Mol. Immunol, 17, 621, 10.1038/s41423-020-0458-z · DOI · Paper page
  13. Yurkovetskiy, L. , Pascal, K.E. , Tompkins-Tinch, C. , Nyalile, T. , Wang, Y. , Baum, A. , Diehl, W.E. , Dauphin, A. , Carbone, C. , Veinotte, K. , et al. (2020). SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain. BioRxiv 2020.07.04.187757.

Cited by

See all 108

Metadata

Authors
Daniloski, Z., Jordan, T. X., Ilmain, J. K., Guo, X., Bhabha, G., tenOever, B. R., & Sanjana, N. E.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2020-06-15
OpenAlex
W3034961138
Cited by
108
References
12
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.